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ANTIFLUORESCEIN  AFFINITY  COLUMNS 
Isolation  and Immunocompetence  of Lymphocytes  That Bind 
Fluoresceinated Antigens In Vivo or In Vitro* 
BY DAVID W.  SCOTT$ 
(From the Division of  Immunology, Department of  Microbiology and Immunology, Duke University 
Medical Center, Durham, North Carolina 27710) 
Since  1969, when  Wigzell  and  Andersson  first  described  the  removal  of antigen- 
reactive lymphocytes with antigen-coated glass bead columns (1), numerous techniques 
have been reported for the elimination or purification of specific lymphocytes or lympho- 
cyte subpopulations. These include, for example, the use of antigen or antibody bound to 
nylon fibers  (2,  3),  plastic tubes  (4),  plastic,  polyacrylamide, or agarose beads  (5-7), 
gelatin layers (8, 9), as well as "insoluble" antigen in the form of cellular monolayers of 
tumor (10), fibroblastoid (11), or red blood cell (RBC) (12) origin, resetting (13), and, most 
recently, the fluorescence-activated cell sorter (FACS) I (14). All of these techniques are 
dependent  on  the  binding  of antigen  via specific membrane receptors  on  normal  or 
sensitized lymphocytes or antibody-forming cells  (AFC).  Elution  of specific cells from 
insoluble  matrices has been  accomplished with  variable yields by either  nonspecific 
(agitation, shear) (1, 2) or specific (antigen) methods (4). With the exception of the FACS, 
each of these techniques requires the preparation of specific immunoabsorbents for each 
antigen used. Isolation with the FACS has the advantage of separation of virtually pure 
lymphoid cells which have been labeled with a  fluorescent antigen  (or antibody).  We 
recently reported that cells that bind fluoresceinated antigen  (FLAG) (or tolerogen) in 
vivo were isolatable with the FACS (15) and described the parameters for the detection of 
fate of these cells in tolerance vs. an immune response (16). 
To isolate these antigen-binding cells in large quantities, however, we have 
developed a technique that takes advantage of fluorescent-antigen labeling as 
well as affinity chromatography over an insoluble matrix (i.e., antifluorescein- 
coupled beads).  This technique is rapid and can be applied to any antigenic 
system into which fluorescein  (FL) can be introduced.  Elution  is accomplished 
with  fluoresceinated  heterologous  antigens.  In  this  paper,  we  describe  the 
principle of this technique and its application for the isolation of cells that have 
bound fluorescent antigens (T dependent and independent) in vivo and in vitro. 
Evidence for the immunocompetence of the isolated cells is presented. 
* Supported by U. S. Public Health Service grant no. AI-10716. 
$ Research Career Development Awardee,  no. 1 KO4 AI-00093. 
1  Abbreviations  used  in this paper:  ABC, antigen-binding cells; AFC, antibody-forming cells; 
AHF, aminoheptyl Ficoll;  a-FL, antifluorescein;  BSA, bovine serum albumin; E, eluted  cell 
population;  FACS,  fluorescence-activated  cell sorter;  FCS,  fetal calf serum; FITC, fluorescein 
isothiocyanate;  FL, fluorescein hapten; FLAG, fluorescent antigen; KLH, keyhole limpet hemocy- 
anin; MEM, minimal essential medium; O, original (unseparated)  cell population;  P, passed cell 
population;  POL, polymerizod flagellin;  SGG, sheep gamma globulin; TNP, trinitrophenyl. 
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Materials and Methods 
Animals.  Male animals  of the following strains  were used  at 2-6  mo of age:  CBA/J  (The 
Jackson  Laboratory,  Bar Harbor,  Maine),  C57BL/6 and  C3H/St  (West Seneca Breeding Labs, 
Buffalo, N. Y.), CBA]CaJ mice (University of Alberta Farms,  Ellerslee, Alta.), and Lewis rats 
(Microbiological Associates, Bethesda,  Md.). 
Antigens and Fluorescein Conjugation.  Polymerized flagellin (POL) from Salmonella adelaide 
SW1338 was the generous gift of Doctors C. Shiozawa and E. Diener of the University of Alberta. 
Trinitrophenylated  sheep gamma globulin  (TNPsSGG) was prepared  as described earlier  (16). 
Aminoheptyl Ficoll (AHF) was prepared  by activating Ficoll (tool wt, 400,000;  Pharmacia  Fine 
Chemicals,  Piscataway,  N. J.) with limiting amounts  of cyanogen bromide and then adding a 
molar excess of diaminoheptane. The AHF  was dialyzed extensively and conjugated at room 
temperature with trinitrobenzene  sulfonic  acid  in cacodylate buffer  (17)  to yield TNP2oAHF. 
Keyhole limpet hemocyanin (KLH) was the kind  gift  of  Dr. M. Rittenberg,  University of  Oregon 
Medical School. 
Fluorescein  isothiocyanate  (FITC)  conjugation (1  mg FITC/40  mg protein)  was  carried  out  at  pH 
9.5  in 0.05  M  sodium carbonate at  0°C as modified from Goldman's procedures (16,  18).  The final 
FL-labeled proteins  and their  average molar ratios  of  FL were: FLsKLH  (per  100,000  daltons), 
FLsbovine serum albumin, FL15horse gamma globulin,  FL3_sSGG, and TNPsFL2.sSGG. FL-POL 
contained 1  FL group  per  40,000  dalton  monomer. FL  cells  were  prepared  by  adding  0.5  ml FITC (2 
mg/ml)  in  carbonate to  each  I  ml  of  cells  (15%  RBC or  10  s  nucleated  spleen  cells)  for  20  rain  at  room 
temperature  and washing extensively.  The number of  FL groups on  conjugated red cell  or  spleen 
cell  membranes was not  quantitatively  ascertained,  although all  these cells  were observed to  be 
brightly  fluorescent  in a Leitz  Ortholux II  microscope. 
Preparation of  Antifluorescein  [a-FL] and a-FL Columns.  a-FL-KLH was produced by re- 
peated injection  of  a male pony with Img FLsKLH in  complete  Freund's adjuvant.  The a-FL was 
precipitated  from  the  serum  with  sodium  sulfate  and  then  affinity  purified  by  passage  through  and 
elution  from  a FL15horse gamma globulin-Sepharose 4B column, which  was  prepared  according to 
Schlossman  and  Hudson (7).  This  affinity  purified  a-FL  was  then  conjugated to  Sephadex G-200  or 
Sepharose  4B as above (7).  Preliminary  experiments  determined that 3 ml of  the a-FL beads  had 
the  capacity  to  specifically  retain  at  least  108  FL-RBC, 25 × 10  ~  FL  lymphocytes, and 10  -8  tool  of  FL 
in  the form of  FL-AHF (see  below). 
Column Isolation and Elution.  Columns were prepared from disposable 10-ml syringes CPlas- 
tipak," Becton-Dickinson & Co., Rutherford, N. J.) as follows. The rubber tip of the plunger was 
removed and cut transversely to yield an O ring which was then placed back in the barrel over fine 
nylon mesh to act as a support for the beads. Each column was then packed with 1 ml of Sephadex 
G-25  as  a  bottom  layer  and  then  3  ml  of the  a-FL  beads  (Fig.  1).  Preliminary  experiments 
established that the G-25 layer greatly increased the flow rate  of the columns. All beads were 
stored in phosphate-buffered  saline  (PBS) plus 0.1%  sodium azide which was washed out with 
sterile PBS after the columns were poured. Routinely, columns were prepared in a  laminar flow 
hood,  washed  with  sterile  PBS, and  then  exposed  to  2,000  R T-irradiation  from  a 1~Cs  source.  After 
irradiation,  the  columns  were  equilibrated  with  cold  medium (except  where  indicated),  the  cells  to 
be  separated were  carefully  added (at  1-2 × 108/mI),  and  the  columns  clamped  offfor  5  rain  at  room 
temperature. The columns were opened and washed with 15-50  ml of  medium to  yield  a "passed" 
(P)  cell  fraction.  At this  point,  5-15 mg FLsBSA at  5 mg/ml was added, the beads gently mixed, 
and the columns washed with 10  ml FLsBSA at 500/~g/ml, followed  by medium. This fraction  is 
referred  to as the eluted (E) cells.  In preliminary experiments, equivalent amounts of  FLsBSA 
were added  to  the original  (unseparated)  and P cell  preparations  to  control  for  the effect  of  excess 
FLsBSA on the responsiveness of E  cells.  No effect  of FLsBSA on the responsiveness of any 
fractions  was  observed.  It  should be  noted for  the  TNP experiments  that  FL  and  TNP do  not  cross- 
react as measured directly  by plaque assay, inhibition  of PFC, or cross-tolerance  (D. Scott, 
unpublished  observations). 
All cell  fractions  were then washed three times in the appropriate medium and the cells 
examined for  fluorescence  and immunocompetence vs. specific  and unrelated antigens.  Since the 
number of  E cells  was quite  small  and may be  deficient  in  accessory  cell  function,  the  competence 
of  this  fraction  was tested  by adding these cells  to  an aliquot  of  P cells  (P plus E, reconstituted 
fractions),  except where noted.  The preparation of  fluorescent  antigen-labeled  cells  for  each test 
situation  is  described  in the Results section. DAVID  W.  SCOTT  71 
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FIG.  i.  Protocol for the isolation of  fluorescein-labeled cells.  See Materials and Methods 
for details. 
Cell Culture Technique.  In vitro responses were performed in modified Marbrook vessels (1.0- 
1.5 cm inner chamber diameter) with 10-15  x  106 mouse spleen cells in 1 ml minimal essential 
medium (MEM) plus 10% fetal calf serum (FCS), nonessential amino acids, i mM pyruvate, I mM 
glutamine, pen-strep (100 U and 100 i~g/ml, respectively), and 5 ×  10 -s M mercaptoethanol, except 
where: noted. The outer chambers contained 10 ml of the above medium with 5% FCS, except for 
the POL experiments in which 50 ml was used with no mercapteethanol. The antigens employed 
(and ohallenged doses per culture) were SRBC (4 x  10e), TNP-SRBC (17) (4 x  10e), TNP-Ficoll (50 
ng),  POL  (100  ng),  irradiated  allogeneic  and  TNP-modified  syngeneic  spleen  cells  (re- 
sponder:stimulator cell  ratios  =  10:1).  All AFC  responses were  assayed  after 4  days  in  Cun- 
ningham chambers  (19)  using  SRBC  or  TNP-horse  RBC  (17)  as  targets.  AFC  to  POL  were 
measured as described by Diener (20).  Cell-mediated lysis, on day 5 of culture, was performed at 
"killer":target ratios of 10:1-50:1 in 12  ×  75-ram centrifuge tubes. Mixtures in a total vol of I ml 
were centrifuged at 800 rpm for 5 min at room temperature at the initiation of assay. 5~Cr release 
was measured after 4 h  (except as noted) by the following formula: 
percent specific release =  experimental cpm -  medium background x  100% 
total (HC1) releasable cpm 
Target cells included TNP-modified or unmodified C3H fibroblasts (clone 1D) or the C57BL tumor, 
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Results 
Basic Principles and Preliminary Experiments.  In all experiments, lympho- 
cytes were exposed to various FLAGs either by in vivo injection or by incubation 
in vitro  (Fig.  1).  Specific lymphocytes bind antigen  via surface receptors and 
maintain antigen on their surface for at least minutes to hours or even days (16, 
21, 22). Since the antigen is fluorescent, these cells can be directly observed (14, 
15) and should theoretically bind to the  a-FL beads. Furthermore,  after unre- 
lated (nonbound) cells are washed off, the specific cells should be competed off 
with excess FL-protein. This has been tested in several different systems. 
Initially, columns were calibrated with FL-RBC as described in Materials and 
Methods. Each 3-ml column was found to retain  1-2  ×  10  s labeled RBC, up to 
80% of which were elutable with FL-BSA. Preliminary experiments with spleen 
cells,  labeled with  FL-anti-immunoglobulin,  established that  up to 2.5  x  107 
immunoglobulin-positive  lymphocytes were bound by each  column;  however, 
less than 50% of these bound lymphocytes were elutable unless the beads were 
gently suspended with a  Pasteur pipette when the FL-BSA was applied.  The 
eluted cells, as expected, were >95% immunoglobulin positive. 
To establish that antigen-binding  cells (ABC) could be bound to and eluted 
from these columns,  we examined  the ABC from Lewis rats  which had been 
injected with FL-SGG 1 h  earlier  (16). The washed but unseparated  (original) 
spleen cell population contained 50 positive fluorescent lymphocytes per 100,000 
cells. After passage through a 3 ml a-FL column, no positive cells were detecta- 
ble in over 20,000 scanned (<5/100,000). The eluted cell fraction (approximately 
1% of the total cell number applied) contained 30% positive cells (equivalent to 
30,000  per 100,000)  or a  600-fold purification. 
However, these experiments merely demonstrated the capacity of our columns 
and the efficacy of elution of FL-labeled cells. These data say nothing about the 
immunocompetence of the various populations. The following experiments bear 
on this point. 
Isolation ofPOL-Specific Lymphocytes.  In this experiment, CBA/CaJ spleen 
cells were incubated with FL1POL at 100 ng/ml or 10/~g/ml for 30 rain at 37°C, 
washed three times, and then applied to the columns. During this time interval, 
antigen  is bound to a  similar portion of spleen cells at both concentrations  of 
POL. It should be noted that 10 ftg is normally a tolerogenic dose when cells are 
continuously  exposed  to  POL  for  6  h  to  4  days;  however,  no  reduction  in 
responsiveness is observed if spleen cells are incubated with POL for only 30 rain 
and then washed (reference 23 and results below). The immunocompetence of 
each fraction  (or combined P plus E) was then determined, after further wash- 
ing, by culturing the fractions with an immunogenic concentration of POL (100 
ng/ml). As a specificity control, all fractions were cultured with sheep RBC. As 
can be seen in Table I, the P cells (at either dose of FL-POL) were significantly 
reduced in their responsiveness to POL (but not to SRBC). More importantly, 
the responsiveness of the P plus E fraction was restored to near normal levels. 
This indicates that the E fraction contains cells necessary for the AFC response 
to POL, whether immunogenic  or tolerogenic levels of FL-POL were initially 
used to label. 
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TABLE  I 
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Group  Treatment group 
AFC/culture (mean -+ SE) 
vs. POL  vs. SRBC 
1  Tolerogenic dose*  Original  2,613  _  554  3,750 +_ 782 
(10 ~g/ml) 
2  "  Passed  407  _+  67  2,775 •  460 
3  "  Passed +  eluted  1,560  _+ 293  3,175  ~- 805 
4  Immunogenic dose  Original  2,080  +_ 342  4,500 ~- 564 
(100  ng/ml) 
5  "  Passed  567  _+  81  3,550  ±  892 
6  "  Passed +  eluted  1,370  +_ 360  2,900  _+  533 
Group 2 significantly  less than group 1 or 3 vs. POL and group 5 significantly  less than group 4 or 
6 vs. POL. No significant difference in SRBC responses. 
* CBA/CaJ spleen cells were incubated for 30 rain at 37°C with tolerogenic (10 ~g/ml) or immuno- 
genic (100  ng/ml) doses of fluoresceinated POL(FLIPOL),  washed, and separated on  anti-FL 
columns as described. All fractions were washed and challenged in Marbrook vessels  with 100 ng 
POL and 0.02% SRBC. AFC were assayed on day 4.  Note, no response to POL was seen if the 
cultures were not challenged with  100 ng POL.  Thus the isolation procedure per se did not 
trigger these cells. 
* See text. 
Cell Precursors.  To determine if TNP-reactive lymphocytes could be isolated 
with  a-FL  columns,  C3H/St  mice  were injected  intravenously  with  1 mg  of 
TNPsFL2.5SGG, and their spleen cells prepared  1 h  later.  Washed spleen cells 
were passed through the columns as described above and cultured as follows. 
One set of original unseparated (O), P, and P plus E fractions was cultured with 
50 ng TNP2oAHF or SRBC. Another  aliquot of O,  P,  and  P  plus E  cells was 
cultured with 2,000 R T-irradiated TNP-C3H splenocytes (or irradiated  C57BL 
spleen cells as a specificity control). As can be seen in Table II, the AFC response 
to TNP2oAHF was significantly reduced in the P fraction, but was restored when 
E  cells were added. The response to SRBC was the same in all cultures. 
Interestingly, when fractions from the same pool of spleen cells were tested for 
the generation of cytotoxic T cells in response to TNP-modified syngeneic cells 
(24), no depletion of activity was observed in the P-cell fraction  (Table III). In 
fact, in several experiments, the cytotoxic response of P or P plus E fractions was 
increased compared to the unseparated  (O) cells.  Further  attempts to remove 
cytotoxic T-cell precursors,  after brief incubation of responders with FL-conju- 
gated stimulating  spleen cells and  column treatment,  were also unsuccessful 
(data not shown). 
Enrichment of Cytotoxic T Lymphocytes.  The previous experiment demon- 
strated that TNP-specific AFC precursors were isolatable with these columns, 
whereas the precursors  of TNP-specific cytotoxic T  lymphocytes were not re- 
moved. This could be because hapten-reactive cytotoxic lymphocytes recognize 
the  hapten  and  part  of the H-2  complex  (24),  and  the  binding  to TNP  on  a 
heterologous carrier, if it occurs, was insufficient under our isolation conditions 
for cell separation.  However, preliminary  experiments,  using fluoresceinated 
syngeneic or allogeneic cells, failed to remove cytotoxic T-cell precursors specific 
for these antigens  (data not shown). Therefore, it became important to demon- 74  ISOLATION  OF  IMMUNOCOMPETENT  LYMPHOCYTES 
TABLE  II 
Isolation of TNP-Specific AFC Precursors* 
Mean PFC  _+  SE/culture (day 5) 
vs. TNP  vs. SRBC 
Original  797 _  73  767 _+ 112 
Passed  156  ±  45  713  ±  164 
Passed +  eluted  742  _+  64  927  -+ 47 
* C3H mice were injected i.v. with 1 mg TNPsFL2.~ SGG (-1 h), their spleens 
washed and separated on  a-FL columns as described. All fractions were 
cultured in Marbrook vessels with TNP-Ficoll (50 ng/culture), SRBC (0.02%/ 
culture), or no Ag (background). Background PFC to TNP (-200) and SRBC 
(-80) have been subtracted. 
TABLE III 
A ttempted Isolation of Killer Cell Precursors* 
Percent ~Cr releases 
Killers 
Targets:  TNP-CL1D  CL1D  EIA 
Original  21.1  ±  2.1  -1.2 _+  1.9  64.2  ±  2.7 
Passed  37.1  ±  4.8  -0.4 _+  1.8  67.1  ±  1.1 
Passed +  eluted  47.8  ±  1.9  -0.4 _+  2.5  73.6  ±  0.7 
C3H mice were injected i.v. with 1 mg TNPsFL~.sSGG(- 1 h), their spleens washed 
and separated on a-FL columns as described. All fractions were cultured in Mar- 
brook vessels with TNP-modified C3H spleen cells (responder:stimulator ratio  = 
10:1) and tested against TNP-modified and unmodified C3H cells (CL1D).  Aliquots 
of each fraction were also sensitized separately vs. C57BL  spleen cells and tested 
against EL4.51Cr release assay on day 5 at 30:1 killer to target ratio (4-h assay). 
Percent  51Cr release  =  (experimental cpm  -  medium  background  cpm)/(total 
releasable cpm  (HC1)),  where background  =  14.5%  (TNP-CL1D),  15.3%  (CL1D), 
and  11.4%  (EL4) and total releasable  =  76.1%  (TNP-CL1D),  77.7%  (CL1D),  and 
82.3%  (EL4). 
strate whether any T-cell population was isolatable using a-FL columns. To test 
this, we employed BALB/c anti-EL4 (H-2 d anti-H-2  ~) cytotoxic peritoneal exu- 
date lymphocytes, which are a  potent population of killer cells  (25) and have 
been shown to bind to EL4 cells or cell monolayers in vitro  (9,  26). BALB/c 
peritoneal cells, harvested on day 11 after an intraperitoneal injection of 25  x 
106 EIA leukemia cells, were mixed at a 20:1 (BALB:EL4) ratio with FL-EL4 and 
centrifuged for 5 min at 800 rpm to promote cell contact. The cell pellets were 
gently resuspended and briefly warmed to room temperature, after which an 
aliquot was removed  (original) and the  remainder passed  through an  a-FL 
column. The original, passed, and FL-BSA eluted cells were washed and tested 
in a 51Cr release assay (2 h) vs. EIA targets. Aliquots of O, P, and E cells were 
also checked for the frequency of FL-EIA and FL-EL4:BALB lymphocyte "ro- 
settes" since 100% of the added EL4 are fluorescent and easily identifiable in a 
ultraviolet microscope.  As  a  control, immune  BALB/c peritoneal  cells  were 
mixed with sham-labeled nonfluorescent EL4 and "separated" over identical DAVID  W.  SCOTT  75 
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Fro.  2.  Depletion and enrichment of killer cell activity.  BALB/c  anti-EL4 peritonea] 
exudate cells were centrifuged with FL-EL4 and then passed through an a-FL column as 
described in the text to yie]d passed (L~) and eluted (n) populations. These fractions and the 
original, unseparated population (©) were then tested against 51Cr-labe]ed EL4 in a 2 h 
chromium release assay at various killer:target cell ratios. As a control, BALB/c anti-EL4 
were also centrifuged with sham-labeled EL4 and "separated" on the columns (A, U, @). In 
Fig.  2 A, the effector:target ratio was not adjusted for the FL-EL4 which were present in 
each fraction. In Fig. 2 B, the number of FL-EL4 in each fraction was subtracted to yield an 
adjusted effeetor:target cell ratio, assuming that FL-EIA acted as "cold" competing targets. 
columns. The results (Fig. 2) show that passage over a-FL columns significantly 
depleted  the  cytotexic activity  of BALB/c cells previously bound to  FL-EL4, 
whereas cytotoxic BALB/c cells exposed to sham-labeled EL4 were present in all 
column fractions,  i.e.,  were not separated.  The results are even more striking 
when one takes into consideration  the FL-EIA also present in the eluted cell 
population,  since these FL-EL4 are not 51Cr labeled and would be expected to 
"compete" with 51Cr-EL4 for effector cell contact (Fig. 2 B). Note, however, that 
the degree of competition by FL-EL4 was not directly tested, so the results in 
Fig. 2 A represent an underestimate of killer cell activity in the eluted fraction, 
while Fig. 2 B is probably an overestimate of this activity. Nevertheless, these 
data  indicate  that  cytotoxic T  cells  can  be isolated  by procedures  similar  or 
identical to those used for the isolation of AFC precursors  (B cells). 
Discussion 
The present experiments  indicate that  a-FL columns can be used to isolate 
antigen-reactive lymphocytes specific for a variety of antigens, if these antigens 
are fluoresceinated (FLAGs) and bound to specific lymphocytes in vitro and in 
vivo. The method is rapid,  versatile,  and requires only one immunoabsorbent, 
the a-FL beads. So far, we have used this methodology to isolate AFC precursor 
(B) lymphocytes specific for POL and TNP (Tables I and II), plaque-forming cells 
specific for SRBC and TNP (L. Greeley and D. Scott, unpublished observations), 
as well as alloantigen-specific cytotexic T lymphocytes (Fig. 2). Further purifica- 76  ISOLATION OF  IMMUNOCOMPETENT  LYMPHOCYTES 
tion of cytotoxic T cells is currently being achieved with EDTA, which is known 
to separate killer cells from their targets  2 (10). 
Although cytotoxic T  lymphocytes have been separated,  we have not been 
able to consistently isolate other T-cell populations, such as helper T cells, cells 
that proliferate in vitro in response to soluble antigen,  or the precursors for 
cytotoxic T  cells  (unpublished data).  Previous workers also failed to  remove 
various T-lymphocyte populations  with  antigen-affinity columns  (1,  6).  It  is 
noteworthy that Rubin recently reported (27) that affinity columns may avidly 
retain  a  suppressor  T-cell  population;  thus,  the  passed  cell  fractions in  his 
experiments gave augmented helper reactivity, but diminished B-cell activity. 
Our  columns may also  retain  a  suppressor  population  as  evidenced by  the 
increased cytotoxic response of the passed cells in Table III. However, this has 
not been rigorously tested. 
It should be noted that the a-FL columns do not yield "pure" populations at 
present, as can be achieved with the FACS, although these columns can be used 
as  a  substitute  "poor man's cell sorter."  However, this  methodology is  more 
rapid than the FACS, yields immunocompetent populations, and can readily be 
carried out under aseptic conditions. Further purification of the eluted cells can 
presumably be  achieved by  more  extensive  washing  of the  columns before 
elution or by rerunning the eluted cells. 
Present methods for the isolation of specific lymphocytes require their interac- 
tion, via their receptors, with antigen or anti-idiotype serum (28). This interac- 
tion,  by definition, means that they are not longer technically immunologic 
virgins (although their membranes may still be "intact"). It is clear from the 
experiments with FL-POL, with tolerogenic or immunogenic concentrations of 
antigen, that these cells are still immunocompetent. That is, the brief interac- 
tion with antigen, per se, can be done under conditions that do not significantly 
induce nor suppress a subsequent response. Thus, purified antigen-reactive cells 
could be isolated at various stages of the immune response or tolerance induc- 
tion and studied in large numbers. In addition, purified antigen-specific cells 
may now be cloned, after viral transformation or cell fusion, and analyzed in 
much the same way as myeloma cells were previously characterized. 
Summary 
A new method for the isolation of specific immunocompetent lymphocytes has 
been described in which lymphocyte populations are exposed to fiuoresceinated 
antigens (FLAGs) in vivo or in vitro, and the FLAG-binding cells retained on 
antifluorescein affinity columns. Specific cells are then eluted with an unrelated 
FL-labeled protein and shown to be fully immunocompetent. This methodology 
has been applied successfully in diverse antigenic systems including polymer- 
ized flagellin  and  TNP-specific  B  cells  and  alloantigen-reactive cytotexic T 
lymphocytes. The method is rapid, inexpensive (requiring only antifluorescein 
beads), and can be applied to any antigens (or antibodies) in which a fluorescein 
group can be introduced. 
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